Psychotropic Medications Weight Gain: A Clinical Dilemma Looked Through the Lens of Therapeutic Challenges, Complementary Approaches and Pharmacotherapies

References (63)

1. 1 Cannabis Use and Psychosis: A Longitudinal Population-based Study [DOI]
2. 2 Association between Reduced Sleep and Weight Gain in Women [DOI]
3. 3 Breastfeeding and asthma and allergies: a systematic review and meta‐analysis [DOI]
4. 4 Effect of Hypericum perforatum (St John's Wort) in Major Depressive Disorder [DOI]
5. 5 Lifestyle Modification for the Management of Obesity [DOI]
6. 6 Proposed diagnostic criteria for night eating syndrome [DOI]
7. 7 Dietary Polyphenols and Obesity [DOI]
8. 8 Natural AChE Inhibitors from Plants and their Contribution to Alzheimer’s Disease Therapy [DOI]
9. 9 Enhanced Weight Loss With Pramlintide/Metreleptin: An Integrated Neurohormonal Approach to Obesity Pharmacotherapy [DOI]
10. 10 Pathophysiological mechanisms of increased cardiometabolic risk in people with schizophrenia and other severe mental illnesses [DOI]
11. 11 Pharmacotherapies for Obesity: Past, Current, and Future Therapies [DOI]
12. 12 Intentional weight loss and changes in symptoms of depression: a systematic review and meta-analysis [DOI]
13. 13 Evaluating an individualized lifestyle and life skills intervention to prevent antipsychotic‐induced weight gain in first‐episode psychosis [DOI]
14. 14 Dehydroepiandrosterone (DHEA): Hypes and Hopes [DOI]
15. 15 Amphetamines for attention deficit hyperactivity disorder (ADHD) in adults [DOI]
16. 16 Pharmacological Strategies to Counteract Antipsychotic-Induced Weight Gain and Metabolic Adverse Effects in Schizophrenia: A Systematic Review and Meta-analysis [DOI]
17. 17 Bariatric Surgery in the United Kingdom: A Cohort Study of Weight Loss and Clinical Outcomes in Routine Clinical Care [DOI]
18. 18 Effect of Fenugreek Fiber on Satiety, Blood Glucose and Insulin Response and Energy Intake in Obese Subjects [DOI]
19. 19 Herbal medicines in the treatment of psychiatric disorders: a systematic review [DOI]
20. 20 Environmental and Genetic Risk Factors in Obesity [DOI]
21. 21 Association of Post‐Traumatic Stress Disorder and Obesity in a Nationally Representative Sample [DOI]
22. 22 Pharmacological Therapies for Obesity [DOI]
23. 23 The Effects of Lifestyle Interventions on (Long-Term) Weight Management, Cardiometabolic Risk and Depressive Symptoms in People with Psychotic Disorders: A Meta-Analysis [DOI]
24. 24 Attenuation of Olanzapine-Induced Weight Gain With Reboxetine in Patients With Schizophrenia: A Double-Blind, Placebo-Controlled Study [DOI]
25. 25 Review Article: Herbal Approach for Obesity Management [DOI]
26. 26 Adverse Endocrine and Metabolic Effects of Psychotropic Drugs [DOI]
27. 27 Safety Profile of Iloperidone [DOI]
28. 28 Galanthamine, a Natural Product for the Treatment of Alzheimers Disease [DOI]
29. 29 Systematic Review and Meta-analysis of Pharmacological Interventions for Weight Gain from Antipsychotics and Mood Stabilizers [DOI]
30. 30 Psychiatric Diagnosis as an Independent Risk Factor for Metabolic Disturbances [DOI]
31. 31 Management of Schizophrenia with Obesity, Metabolic, and Endocrinological Disorders [DOI]
32. 32 Timosaponin AIII inhibits melanoma cell migration by suppressing COX ‐2 and in vivo tumor metastasis [DOI]
33. 33 Weight Gain, Obesity, and Psychotropic Prescribing [DOI]
34. 34 Weight Change From 3-Year Observational Data [DOI]
35. 35 Alternative/Complementary Therapies [DOI]
36. 36 A fenugreek seed extract selectively reduces spontaneous fat consumption in healthy volunteers [DOI]
37. 37 Drugs in the Pipeline for the Obesity Market [DOI]
38. 38 HERBAL MEDICINES USED IN THE TRADITIONAL INDIAN MEDICINAL SYSTEM AS A THERAPEUTIC TREATMENT OPTION FOR OVERWEIGHT AND OBESITY MANAGEMENT: A REVIEW
39. 39 Experience (Mostly Negative) with the Use of Sympathomimetic Agents for Weight Loss [DOI]
40. 40 Relationship between body mass index and insulin resistance in patients treated with second generation antipsychotic agents [DOI]
41. 41 Design of the Lifestyle Interventions for severe mentally ill Outpatients in the Netherlands (LION) trial; a cluster randomised controlled study of a multidimensional web tool intervention to improve cardiometabolic health in patients with severe mental illness [DOI]
42. 42 Effectiveness of a Cognitive Behavioral Weight Management Intervention in Obese Patients With Psychotic Disorders Compared to Patients With Nonpsychotic Disorders or No Psychiatric Disorders [DOI]
43. 43 A Diet and Fitness Program Similarly Affects Weight Reduction in Schizophrenia Patients Treated with Typical or Atypical Medications [DOI]
44. 44 Metformin for metabolic dysregulation in schizophrenic patients treated with olanzapine [DOI]
45. 45 Effect of adjunctive ranitidine for antipsychotic-induced weight gain: A systematic review of randomized placebo-controlled trials [DOI]
46. 46 Future Research Needs for Childhood Obesity Prevention Programs
47. 47 Effectiveness of St John's Wort in Major Depression [DOI]
48. 48 A Multidisciplinary Treatment for Morbid Obesity: Therapeutic Experience with Groups [DOI]
49. 49 Using Herbal Remedies to Maintain Optimal Weight [DOI]
50. 50 Isolating the Effect of Major Depression on Obesity: Role of Selection Bias [DOI]
51. 51 Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128·9 million children, adolescents, and adults [DOI]
52. 52 Interventions for preventing obesity in children [DOI]
53. 53 The Canadian Network for Mood and Anxiety Treatments (Canmat) Task Force Recommendations for the Management of Patients with Mood Disorders and Select Comorbid Medical Conditions [DOI]
54. 54 Cushing’s Syndrome in Pediatrics [DOI]
55. 55 Spiritual and Religious Healing Practices: Some Reflections from Saudi National Center for Complementary and Alternative Medicine, Riyadh [DOI]
56. 56 Long-term psychiatric inpatients’ perspectives on weight gain, body satisfaction, diet and physical activity: a mixed methods study [DOI]
57. 57 Associations between parity and maternal BMI in a population‐based cohort study [DOI]
58. 58 The Association between Food Addiction and Early Maladaptive Schemas in Overweight and Obese Women: A Preliminary Investigation [DOI]
59. 59 Implications of Off‐Target Serotoninergic Drug Activity: An Analysis of Serotonin Syndrome Reports Using a Systematic Bioinformatics Approach [DOI]
60. 60 Second-Generation Antipsychotics in Adolescent Psychiatric Patients: Metabolic Effects and Impact of an Early Weight Change to Predict Longer Term Weight Gain [DOI]
61. 61 A cross-continental analysis of weight gain, psychiatric diagnoses and medication use during inpatient psychiatric treatment. The international study on physical illness in mentally ill [DOI]
62. 62 Psychotropic Medication-induced Weight Gain or Loss Looked through the Lens of Age and Psychiatric Diagnoses: A Narrative Review [DOI]
63. 63 Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: The evidence report [DOI]

Cited by 0

No indexed citations yet.

Related research

• Metabolic Syndrome among Healthcare Workers in a Tertiary Hospital in South-South, Nigeria — shares topic coverage
• Dietary Pattern and Prevalence of High Blood Pressure among Adult Traders in Port Harcourt, Nigeria — shares topic coverage
• Impact of the Diet Profile and Alcohol Consumption on Cardiometabolic Risks in Dschang Health District-Cameroon — shares topic coverage
• Gender Specific Predictive Performance and Optimal Threshold of Anthropometric Indices for the Prediction of Hypertension among a Ghanaian Population in Kumasi — shares topic coverage
• Metabolic Syndrome and Kidney Damage: Prevalence and Assessment of Risk among Apparently Healthy Resident of Ado Ekiti, South West Nigeria — shares topic coverage